Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cancer Genome Atlas Database
Background. Pancreatic cancer is one of the most malignant tumors of the digestive system, and its treatment has rarely progressed for the last two decades. Studies on m6A regulators for the past few years have seemingly provided a novel approach for malignant tumor therapy. m6A-related factors may...
Main Authors: | Bi Lin, Yangyang Pan, Dinglai Yu, Shengjie Dai, Hongwei Sun, Shengchuan Chen, Jie Zhang, Yukai Xiang, Chaohao Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2021/5573628 |
Similar Items
-
Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases
by: Pan Cai, et al.
Published: (2021-01-01) -
Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway
by: Yukai Xiang, et al.
Published: (2018-01-01) -
Prognostic Nomogram for pancreatic cancer with lung metastasis: a SEER database-based study
by: Jiachun Ding, et al.
Published: (2021-03-01) -
microRNA based prognostic biomarkers in pancreatic Cancer
by: Shixiang Guo, et al.
Published: (2018-05-01) -
Systematical Analysis of the Cancer Genome Atlas Database Reveals EMCN/MUC15 Combination as a Prognostic Signature for Gastric Cancer
by: Wentao Dai, et al.
Published: (2020-02-01)